loader from loading.io

Peter Hendricks Ph.D. - Psilocybin for Cocaine Use

Psychedelics Today

Release Date: 06/30/2020

Solidarity Fridays - Week 19 show art Solidarity Fridays - Week 19

Psychedelics Today

In today's Solidarity Fridays episode, Joe and Kyle sit down and talk about recent items in the news, and dive deep into analyzing 2 articles that are very critical of MAPS' involvement with the police, military, and government.  They first discuss Canada-based nonprofit TheraPsil's recent win of four people with incurable cancer being granted the ability to use psilocybin for end-of-life therapy, and how this framework could be copied and used in the US through the Right-to-try act, signed into law in 2018.   They then discuss Dimitri Mugianis's recent article in Salon, which...

info_outline
John Selby - Professional Guidance Integrating Cannabis and Mindfulness show art John Selby - Professional Guidance Integrating Cannabis and Mindfulness

Psychedelics Today

In today's episode, Joe speaks with spiritual coach, author, and creator of the upcoming High Together app, John Selby. Selby's most recent book is titled Cannabis for Couples: Enhance Intimacy and Elevate Your Relationship. Selby talks about how he got to where he is today, from signing up for a hypnosis research center at Princeton that turned out to be a secret government NIH psychedelic research center studying if psychedelic states could be induced through hypnosis, to working on the first quantitative EG study of heavy LSD users to determine if it caused permanent damage (that was marred...

info_outline
Solidarity Fridays - Week 18 show art Solidarity Fridays - Week 18

Psychedelics Today

In today's Solidarity Fridays episode, Joe and Kyle sit down to discuss recent topics in the news and analyze the ongoing debate of decriminalization vs. legalization.  They first discuss the story of LSD chemist William Leonard Pickard, who was released from prison on July 27th due mostly to his age, health status and risk for contracting Covid-19, and while it's great that he's out, how it changes nothing about the conspiracy surrounding his arrest ("Halperngate") and the very questionable DEA claims of LSD availability decreasing by 95% after his imprisonment.  They then talk...

info_outline
Lauren Taus - Wellness through Yoga, Meditation and Psychotherapy show art Lauren Taus - Wellness through Yoga, Meditation and Psychotherapy

Psychedelics Today

In today's episode, Kyle interviews Lauren Taus: yoga instructor with 20 years of experience, host of the Inbodied Life podcast, and psychotherapist specializing in ketamine-assisted psychotherapy.  Taus talks about growing tired of more traditional therapy and cognitive loops so many people find themselves in through cognitive behavioral therapy leading to her taking a break from therapy altogether, trying psychedelics with her brother, learning of psychedelics being used therapeutically, and coming out of the psychedelic closet to her father (who now works with her).  She speaks...

info_outline
Solidarity Fridays - Week 17 show art Solidarity Fridays - Week 17

Psychedelics Today

In today's Solidarity Fridays episode, Joe and Kyle sit down and discuss two news stories emerging from Portland, Oregon- first, paramilitary-like federal agents showing up in unmarked cars and arresting protestors, and second, the beating and pepper-spraying of one of those protestors, Christopher David.  They look at these events from multiple perspectives- what fears are driving the opinions of people who are against these protests? Why does there always seem to be money when it comes to military expenses, but never any money when it comes to the wellbeing of people? How many police...

info_outline
Dr. Malin Vedøy Uthaug - Ayahuasca and  5-MeO-DMT Research show art Dr. Malin Vedøy Uthaug - Ayahuasca and 5-MeO-DMT Research

Psychedelics Today

In this episode, Kyle speaks with Imperial College London research assistant and past guest, Dr. Malin Vedøy Uthaug, who just earned her doctorate and published her dissertation on Ayahuasca and 5-MeO-DMT research. Uthaug discusses how she started working in this field, why Prague is a good place for research, what past research has led to today, how certain factors could predict whether someone would have a more challenging or more mystical experience, how these experiences can treat people with PTSD differently, what dissociation actually means, the differences between vaporized 5-MeO-DMT...

info_outline
Solidarity Fridays- Week 16 show art Solidarity Fridays- Week 16

Psychedelics Today

In today’s Solidarity Fridays episode, Joe and Kyle sit down and talk about various topics in the news and dive deep into somatic psychology.  They first discuss Canadian mushroom life sciences company Cybin Corp's recent collaboration with drug delivery company IntelGenx to create an orally dissolvable film to administer psilocybin in controlled doses. This feels to them like the early days in the expansion of cannabis offerings, and how, for people with difficulty swallowing or pill-phobia, this may be the best option for psilocybin.  Next, they talk about a recent study of 65...

info_outline
Mike Crowley - Secret Drugs of Buddhism show art Mike Crowley - Secret Drugs of Buddhism

Psychedelics Today

In today’s episode, Joe interviews Author Mike Crowley to talk about his book, Secret Drugs of Buddhism. Links About Mike Crowley Michael Crowley was born February 26th, 1948 in Cardiff, Wales. He began studying Buddhism with a Tibetan lama in 1966, becoming an upasaka of the Kagyud lineage in 1970. In order to augment his Buddhist studies, he acquainted himself with Sanskrit, Tibetan, and Mandarin Chinese. Mike has lectured at the Museum of Asia and the Pacific, Warsaw, the Jagiellonian University, Cracow, the California Institute of Integral Studies, San Francisco, and at the University...

info_outline
Solidarity Fridays - Week 15 show art Solidarity Fridays - Week 15

Psychedelics Today

In today’s Solidarity Fridays episode, Joe and Kyle sit down and talk about various topics in the news. They first discuss Rise Wellness (a company focused on teaching people how to microdose psilocybin)'s recent merger with CannaGlobal and Sansero Life Sciences to become CannaGlobal Wellness, and why many smaller companies are merging, and why Canada may be a hot new destination point for these companies. Joe suggests a new idea of helping people microdose through the use of a transdermal patch.  They talk about psychology today and the idea of no theory being complete without...

info_outline
Jesse Gould and Keith Abraham - Heroic Hearts Project: Connecting Veterans to Psychedelic Treatment show art Jesse Gould and Keith Abraham - Heroic Hearts Project: Connecting Veterans to Psychedelic Treatment

Psychedelics Today

In today's episode, Joe interviews Jesse Gould, founder and president of the Heroic Hearts Project, a nonprofit organization that connects military veterans to ayahuasca retreats, and Keith Abraham, head of the newly created Heroic Hearts UK branch. They discuss the similarities of their military pasts and post-combat struggles, and how they both took part in ayahuasca ceremonies at Peru's La Medicina, where they eventually met. They note the need to create the UK branch came from the realization that UK vets simply weren't getting as much attention as those in the US. They talk about the...

info_outline
 
More Episodes

In this episode, Joe speaks with Peter Hendricks, Ph.D. and Associate Professor at the University of Alabama, currently involved in researching the effects of psilocybin on people dealing with cocaine-related substance use disorder. 

He discusses the details of the pilot trial (following the Johns Hopkins model, with music created by Bill Richards), some early findings and speculations, what music might work best for these sessions, how excited he is to bring these findings to the criminal justice system, and how religion and tribalism come into play when looking at what people get out of these psychedelic experiences.

Hendricks points out that while psilocybin is currently being researched as a treatment for tobacco use (by Matthew Johnson at Johns Hopkins) and alcohol use (by Michael Bogenschutz at NYU), this is the first large study with cocaine and could lead to the first medication for major stimulants. And while there have been many studies on psilocybin in general, they’ve rarely been focused on the people he’s working with, who are often poorer, less educated, often out of work, and usually struggling more than those typically involved in these studies. They also talk about what research of the past has given us data-wise, and how inspirational it has been to the work being done today. 

Notable Quotes

“The participants in our trial- they haven’t read Michael Pollan’s book or others. They’re not in the know. I’ll have to explain to them what the drug is, and the common reaction is, ‘uhh, so you’re going to help me stop getting high by getting me high?’ and I’ll try to explain how the drug might differ from others, from more addictive drugs like cocaine. And as we know, it’s an ineffable experience- it’s a difficult experience to put to words…. I’m honored and I have admiration for our participants because they have the courage to dive into this study conducted at a University by people they’ve never met. It can be a very frightening experience and they say, ‘you know what, I’ve tried everything. At this point, I’m desperate, let’s give it a try.’ I probably couldn’t overstate how much courage it takes for them to do what they do. I don’t know that I could do it myself.” 

“I think for most of the world’s fates, the tenants are that we’re all in this together, and we’re bound by love. And that really might be the message that most people get from psychedelics, but similar to religion, sometimes that message is perverted a bit and what you take from it is, ‘my in-group is what’s most important and I’m going to act to preserve my own tribe, even if it means treating others in an awful, inhumane way…’ Sometimes experiences that are really meant to foster a connection with everybody can go haywire and we have to be aware of that”

“One criticism of some of the studies conducted so far has been, how do we know that psilocybin might have these effects on a sample that isn’t all college-educated or doctorates or who are Professors at Universities who make more than 100,000 dollars per year and live comfortably? How do we know that this experience would have any meaning to somebody who’s making less than 10,000 per year, who has a fifth-grade education, who’s unemployed and homeless? I think in large part, this study might answer that question. If we find an effect, then we can say it appears to also have an effect among those who look different and whose life circumstances are much different than some of the earlier participants.”

Links

Twitter

Heffter Research Institute

 

Support the show

Navigating Psychedelics

 


About Peter Hendricks PhD

Dr. Hendricks received his doctorate in clinical psychology from the University of South Florida and completed a post-doctoral Fellowship in Drug Abuse Treatment and Services Research at the University of California, San Francisco. His research centers on the development of novel and potentially more effective treatments for substance dependence, with specific areas of focus on tobacco, cocaine, and polysubstance dependence in vulnerable populations.